“Glaucoma Market” report has been added to DelveInsight
Glaucoma Overview
Glaucoma describes a group of conditions in which there is characteristic cupping of the optic disc with corresponding visual field defects, due to retinal ganglion cell loss. It is a progressive condition and the most common cause of irreversible blindness worldwide.
Glaucoma Market
The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Glaucoma market.
Request free sample copy @ https://www.delveinsight.com/sample-request/glaucoma-market
Glaucoma Market: Geography Covered
Glaucoma Market: Key Players
Glaucoma Market: Drugs/Therapies
Glaucoma Symptoms
The sign and symptoms of Glaucoma differ by subtypes. OAG symptoms includes an increase in IOP, open anterior chamber angle and optic disc changes seen on clinical examination such as high cup to disc ratio, cup to disc ratio asymmetry between eyes, vertical elongation of the cup, etc. while narrow-angle glaucoma symptoms are intense eye pain, headaches or migraines, fuzzy lighting or halo figures, pupil dilation, vision troubles, bloodshot eyes, and physical sickness.
Glaucoma Risk Factors
The risk factors of Glaucoma include older age, family history of glaucoma, African ancestry, nearsightedness, high IOP, low blood pressure, use of topical corticosteroids, inflammation, and tumor.
Glaucoma Treatment
The only form of treatment that has been shown to be efficacious and is generally accepted for the prevention of glaucoma progression is reduction of the intraocular pressure. In patients with open-angle glaucoma, the intraocular pressure can be reduced with regularly applied eyedrops, laser therapy, and/or surgery.
Glaucoma Market: Treatment Market Report
The main goal of glaucoma treatment is to increase the quality of life through the reduction of IOP to preserve visual function. In the process of IOP reduction, an ideal medication should have a schedule that is simple to follow, be least interrupting with a patient’s life, highly tolerable and affordable. However, the medical treatment of glaucoma has associated side effects, complications, and costs.
There are several risk factors like age >60 years, genetic predisposition, certain eye characteristics (such as a pupillary defect, thin cornea, myopia), low educational status, smoking, African descent, and visual problems, which are associated with this indication and, thus, the treatment pattern varies accordingly.
Glaucoma Market: Report Insights
There are three mainstays for lowering eye pressure, i.e. medication, laser, and surgery. The two types of laser treatments currently used are Selective Laser Trabeculoplasty (SLT) and Argon Laser Trabeculoplasty (ALT). Surgery for Glaucoma includes Cataract Surgery, Micro-Invasive Glaucoma Surgery (MIGS), Trabeculectomy, Drainage Implant Surgery, and Ciliary Body Ablation. There is an array of medications to lower the intraocular pressure in Glaucoma, which are divided into five major classes, i.e., Prostaglandin Analogs, Rho kinase inhibitor, Beta Blockers, Nitric oxides, Diuretics, Cholinergic Agonists (Parasympthomimetics), and Alpha Agonists. Monotherapy and combination therapy should be given for effective treatment of glaucoma.
Table of content
Glaucoma Market: Emerging Therapy Assessment
Various pharmaceutical companies have started working toward the development of the novel product for this indication. Pharmaceutical companies, like Sun Pharma Advanced Research Company (SPARC) Limited, Laboratorios Sophia S.A de C.V., Nicox Ophthalmics, etc. are developing products that have the potential to change the glaucoma treatment landscape. Also, the pharmaceutical products of these companies are in late and mid-clinical development stages.
Glaucoma Market: Drivers
Glaucoma Market: Barriers
Why should you buy this report?
About Us
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for life science vertical and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Yash BhardwajEmail: Send EmailPhone: +919650213330Address:304 S. Jones Blvd #2432 City: Las VegasState: NVCountry: United StatesWebsite: https://www.delveinsight.com/